I have 2 lab shep mixes that both had parvo, and a friends dog had it to so i cared for the three of them. My girl pup recovered very quickly, the boy slowly recovered, then attained a cough. Friends recovered parvo pup comes to visit for the weekend, and the boy vomited twice yesterday and had a parvo type defecation today. any suggestions on how to strengthen my boy?

I'm not a vet, but I would suggest giving them parvaid. you can give it to them as a preventative measure and also continue after they have recovered to prevent a relapse. I also have a puppy (st. bernard/boxer) just recovering from parvo – we are giving him parvaid four times a day along with vitamin c and he is getting stronger and healthier by the day. in addition, I have a rottie mix – also a puppy and a 2 yr old German Shepherd mix who were exposed to the virus. We have been giving them parvaid (especially the puppy) four times a day and she has not caught the virus yet.

My dog just recovered from parvo and she had some recurrent symptoms. I fed her unflavored pedilite to keep her hydrated, and made sure she got a lot of rest. she recovered fine. Just make sure the puppy stays hydrated

The Importance of Annual Prostate Cancer Screenings

When September rolls around, people often think about the beginning of school and fall, but a select few may remember that September is Prostate Cancer Awareness Month. According to the American Cancer Society, prostate cancer affects one in six men, with skin cancer being the leading cause of cancer-related death. As a preventative measure, men should get checked annually for prostate cancer. Fortunately, prostate cancer treatment is available and the cancer is curable if detected early.

When should I get Checked for Prostate Cancer?

An annual physical examination can help detect the symptoms of prostate cancer in men. It is suggested that all men age 50 and above have an annual prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE). If your father or brother has prostate cancer, you may want to consider getting tested before the age of 50.

Listed below are the most common symptoms of prostate cancer. There are no specific warning signs or symptoms of early prostate cancer, which is why annual prostate screening is so important.

Symptoms of Prostate Cancer:

- Weak or interrupted flow or urine- Urinating often (especially at night)- Difficulty urinating or holding back urine- Pain or burning when urinating

Other Symptoms of Prostate Cancer:

- Blood in the urine or semen- Pain in the back, hips or pelvis- Difficulty having an erection

Remember, the symptoms of prostate cancer may resemble other conditions or medical problems, so consult your physician for a diagnosis. your physician will also be able to answer any questions about prostate cancer and discuss prostate cancer treatment options.

Why you should get Tested for Prostate Cancer Annually:

The majority of men diagnosed with prostate cancer had no symptoms when prostate cancer was first detected. an annual PSA blood test can detect prostate cancer quickly. Even if your PSA levels are normal (e.g., below 4) an increase in your PSA levels can help detect prostate cancer in its early stages.

What is a PSA Test?

A PSA test is a blood test that detects the amount of prostate-specific antigens (a protein) in the blood. As the prostate enlarges, more of this protein is produced and the increase is detected by the test. During a PSA test, a nurse or doctor takes a sample of blood from your arm and sends it to a lab for analysis. After the test, you will receive a copy of the results with your PSA levels.

A high PSA level may indicate prostate cancer. however, any activity that irritates the prostate may also cause PSA levels to rise.

Causes of an Elevated PSA:

- Benign Prostatic Hyperplasia (BPH), an enlarged prostate- Prostatis, a condition where the prostate becomes inflamed due to an infection- a Prostate Biopsy- recent Ejaculation- Bicycle Riding

Information about PSA:

- According to the American Cancer Society, a PSA level between 4 and 10 may indicate prostate cancer. If this is the case, prostate cancer surgery and radiation are treatment options.- PSA is measured by nanograms per millimeter of blood.- PSA is released into the blood by the prostate gland.- PSA is common in semen.

The most common symptoms of prostate cancer are urinary problems, which include the need to urinate often, trouble urinating and the decreased force in the stream of urine. Other indicators include blood in the urine or in semen as well as frequent pain in the lower back and hips. however, the best way to detect prostate cancer early is by getting an annual PSA test.

Prostate cancer affects more than 186,000 American men each year. Remember the importance of having your doctor check for prostate cancer before you develop any symptoms. If you have any concerns or questions, talk to your doctor. Men diagnosed with prostate cancer have many treatment options, and the sooner you get treated, the sooner you can recover.

Posted on: Wednesday, 1 December 2010, 08:18 CST

(Ivanhoe Newswire) — Nonmelanoma skin cancers are some of the most commonly diagnosed in the U.S. A new study found a possible preventative treatment in the nonsteroidal, anti-inflammatory drug Celecoxib.

Celecoxib is typically used to inhibit the enzyme cyclooxygenase 2, which has been associated with the onset of UV ray-caused nonmelanoma skin cancers.  Since sunscreen has only shown mediocre results in protecting reducing these cancers, researchers at the University of Alabama at Birmingham looked at Celecoxib as an additional preventative measure by testing it on patients with precancerous symptoms.

Lead researcher Craig A. Elmets, M.D. and his associates created a randomized, double-blind trial in which 240 participants with actinic keratoses or precancerous lesions were given either Celecoxib or a placebo.  Results were gathered first during the third, sixth and ninth months of therapy, and then two months after the therapy was completed.

The results showed that the Celecoxib group and the placebo group yielded the same number of precancerous lesions.  by the end of the study, however, the participants in the former group had developed less non-melanoma skin cancers than those in the latter group.

"The findings in the study, which showed that the celecoxib-treated individuals developed fewer nonmelanoma skin cancers than placebo-treated individuals, suggest that cyclooxygenase inhibitors may provide an additional benefit to sunscreens in the prevention of nonmelanoma skin cancers," the researchers wrote.

The FDA shut the study down after a similar study of another cyclooxygenase 2 inhibitor found that the treatment increased the risk of adverse cardiovascular events.  such events were not found in the University of Alabama study, but the researchers believe that the nine month treatment period could have been too short for them to occur.  for example, another cyclooxygenase inhibitor called rofecoxib showed adverse events after a one year trial.

University of California, Irvine editorialists Frank L. Meyskens Jr. M.D. and Christine E. McLaren M.D. recommend that future researchers lower either the dosage or frequency of Celecoxib administration to lessen the adverse cardiovascular events.  They point out that efficacy of Celoxib in reducing the likelihood of nonmelonoma skin cancers, and its failure to reduce the number of precancerous legions, could indicate a difference in the pathways of carcinogens between early and late-stage tumor growth.

SOURCE: Journal of the National Cancer Institute, November 2010

Source: Ivanhoe Newswire

More News in this Category